Skip to main content

ADVERTISEMENT

No reflow

12/08/2016
We present a prospective, double-blinded, randomized, controlled pilot study protocol to test whether tdVAS (50 Hz, 2mm), by 30-minute session directly following primary percutaneous coronary intervention, is feasible, safe, and may enhance...
We present a prospective, double-blinded, randomized, controlled pilot study protocol to test whether tdVAS (50 Hz, 2mm), by 30-minute session directly following primary percutaneous coronary intervention, is feasible, safe, and may enhance...
We present a prospective,...
12/08/2016
Cath Lab Digest
New Ideas
09/05/2016
Low sonic vibroacoustic stimulation (VAS) has shown to enhance clot disruption and stimulate vasodilation. Moreover, transthoracic diastolic timed VAS (tdVAS) (50 Hz, 2 mm) has shown to enhance myocardial relaxation, improve left ventricular...
Low sonic vibroacoustic stimulation (VAS) has shown to enhance clot disruption and stimulate vasodilation. Moreover, transthoracic diastolic timed VAS (tdVAS) (50 Hz, 2 mm) has shown to enhance myocardial relaxation, improve left ventricular...
Low sonic vibroacoustic...
09/05/2016
Cath Lab Digest
Challenges
04/05/2016
Herein, we present a case-based approach in order to discuss the available treatment of NR and to review the clinical significance of ventricular unloading.
Herein, we present a case-based approach in order to discuss the available treatment of NR and to review the clinical significance of ventricular unloading.
Herein, we present a case-based...
04/05/2016
Cath Lab Digest